In the past the main safety approach to problems with both human and pet food centered on response – recalling potentially unsafe foods.
With the passage this year of the Food Safety Modernization Act the emphasis is shifting toward prevention of foodborne illness – stopping unsafe pet and human food before it gets into commerce by requiring food producers and processors to analyze their facilities to see where potential hazards may occur, and then establish preventive controls to address those hazards.
The U.S. Food and Drug Administration will hold a public meeting on Wednesday, April 20, focusing on preventive controls for food facilities as part of the recently enacted FDA Food Safety Modernization Act. The meeting will be held at the FDA White Oak Campus in Silver Spring, Md., from 9 a.m. – 5:30 p.m.
The Food Safety Modernization Act amends the Federal Food, Drug and Cosmetic Act to establish the foundation for a modernized, prevention-based food safety system and gives FDA for the first time a legislative mandate to require comprehensive, science-based preventive controls across the food supply, according to the FDA.
Specifically, the FDA is seeking information on preventive controls used by facilities to identify and address hazards associated with specific types of food and specific processes. The meeting is meant to give the public an opportunity to provide information and share views that will inform the development of guidance and regulations on preventive controls for such food facilities, according to the FDA.
The meeting, “FDA Food Safety Modernization Act: Focus on Preventive Controls for Facilities,” will include introductory presentations by the FDA. The FDA noted, however, that listening to its stakeholders is the primary purpose of the meeting. As such, the FDA will provide “multiple opportunities for individuals to actively express their views by making presentations at the meeting, participating in a total of three 75-minute break-out sessions on the provisions discussed at the meeting and submitting written comments to the docket within 30 days after the meeting.”
The FDA is encouraging persons and groups who have similar interests to consolidate their information for presentation through a single representative.
Requests to make an oral presentation must be made by Friday, April 15. Click here to submit a request.
Advance registration must also be made by Friday, April 15. Click here to register.
Registration to attend the meeting will be accepted onsite on the day of the meeting, as space permits.
For stakeholders who are not onsite, a webcast will be available here.
Electronic comments for Docket No. FDA-2011-N-0251 are due Friday, May 20. Click here to submit an electronic comment.